S H Kelkar And Company Ltd · NSE:SHK
S H Kelkar And — Q2 & H1 FY22 Earnings Presentation
19 slides from S H Kelkar And's earnings presentation, Oct 30, 2021
Slide 1: Cover letter to stock exchanges
October 30, 2021 To To The Manager The Manager The Department of Corporate Services The Listing Department BSE Limited National Stock Exchange of India Limited Floor 25, P. J. Towers, Exchange Plaza, Bandra Kurla Complex, Dalal Street, Mumbai – 400 001 Bandra (East), Mumbai – 400 051 Scrip Code: 539
Slide 2: Q2 & H1 FY22 Earnings Presentation
S H KELKAR AND COMPANY LIMITED Q2 & H1 FY22 Earnings Presentation October 29, 2021
Slide 3: Disclaimer
Disclaimer Certain statements and opinions with respect to the anticipated future performance of SH Kelkar (SHK) in the presentation (“forward-looking statements”), which reflect various assumptions concerning the strategies, objectives and anticipated results may or may not prove to be correct. Suc
Slide 4: Q2 & H1 FY22 Results Overview
Q2 & H1 FY22 Results Overview 3
Slide 5: Management Comment
Management Comment Commenting on the performance, Mr. Kedar Vaze, Whole Time Director & CEO at SH Kelkar and Company Ltd. said: “We have reported a steady performance in the first half of the fiscal. Our European business registered healthy growth on the back of higher consumption and demand trends
Slide 6: Consolidated Summarized P&L Statement
Consolidated Summarized P&L Statement Y-o-Y Y-o-Y Particulars (Rs. crore) Q2 FY22 Q2 FY21 H1 FY22 H1 FY21 Change (%) Change (%) Revenue from Operations 358.3 351.9 1.8% 713.2 543.3 31.3% Sales 335.0 339.7 -1.4% 666.9 531.1 25.6% Sales - Contract Manufacturing 23.3 12.2 91.0% 46.3 12.2 279.5% Other O
Slide 7: Key Developments
Key Developments Strategic order win in the Home Care segment Driven by robust R&D capabilities and innovation strategies, SHK is the only Company of Indian origin to file patents in the field of Fragrance and Novel Aroma Molecules − These patented molecules along with SHK’s strong & well-known ex
Slide 8: Key Developments
Key Developments Update on Debt position As per the amended Schedule III of the Companies Act, 2013, the Company has excluded lease liabilities from its total debt position, which are to be disclosed separately Accordingly, comparative figures for previous periods are also mentioned henceforth.
Slide 9: Financial and Operational Discussions (Y-o-Y)
Financial and Operational Discussions (Y-o-Y) H1 FY22 Revenues from operations stood at Rs. 713.2 crore SHK reported a steady performance during H1. On a year-on-year basis, the Company’s performance is not comparable on account of consolidation of CFF and Nova in Q2 & H1 FY22 − On a like-to-like
Slide 10: Fragrance Division
Fragrance Division Performance during Q2 & H1 FY22 was subdued on account of the second wave of Q2 Q2 Y-o-Y H1 H1 Y-o-Y the pandemic Particulars (Rs. crore) Europe business reported healthy growth FY22 FY21 (%) FY22 FY21 (%) during Q2 & H1 FY22 on the back of higher Revenues from Operations 326.
Slide 11: Flavour Division
Flavour Division Q2 Q2 Y-o-Y H1 H1 Y-o-Y Flavour segment reported stable Particulars (Rs. crore) FY22 FY21 (%) FY22 FY21 (%) performance on the back of steady demand and enquiries from domestic and Revenues from Operations 32.3 30.2 7.0% 56.5 45.0 25.6% international markets EBIT 6.6 8.1 -18.5% 9.
Slide 12: CFF & Nova Performance
CFF & Nova Performance Abridged P&L Statement CFF & Nova delivered robust performance on the back of increasing demand and volume Quarter ending Particulars as a % of Sales off-take in the European markets Sept 30, 2021 Core fragrance segment of CFF business grew Sales – Core Fragrance 60.0 by 3
Slide 13: Balance Sheet Snapshot – As on September 30, 2021
Balance Sheet Snapshot – As on September 30, 2021 347 1,043 791 130 0.3x Networth Net Debt Fixed Assets Cash & Investments & Net Debt to Equity Note: 1) All Figures in Rs. crore 12
Slide 14: Cash Flow Snapshot
Cash Flow Snapshot Particulars (Rs. crore) FY17 FY18 FY19 FY20 FY21 H1 FY22 Net Cash flows from operating activities 102 103 77 205 195 39 Net Cash flow from investing activities -96 -221 -137 -40 -149 -36 Net 6 -118 -60 165 46 3 Note: Cash and cash equivalent includes investments in mutual fund Not
Slide 15: Key Financial Ratios
Key Financial Ratios Particulars (Rs. crore) FY17 FY18 FY19 FY20 FY21 H1FY22 EBITDA margin (%) 17.9 18.0 14.9 14.8 19.3 13.9 PAT Margin (%) 10.6 8.8 8.2 6.3 9.8 14.4 Debt to Equity 0.1 0.2 0.4 0.4 0.4 0.3 Return on Networth (%) 14.3 13.8 12.0 10.0 17.9 12.1 Adjusted Return on Networth (%) 16.1 16.1
Slide 16: Annexure
Annexure 15
Slide 17: Conference Call Details
Conference Call Details S H Kelkar and Company – Q2 & H1 FY22 Earnings Conference Call Time • 11:00 AM IST on Monday, November 01, 2021 Primary dial-in number • +91 22 6280 1141 • +91 22 7115 8042 India Local access Number • +91 70456 71221 (Available all over India) • Hong Kong: 800 964 448 Interna
Slide 18: About Us
About Us S H Kelkar and Company Limited (SHK) is the largest Indian-origin Fragrance & Flavour For further information please contact: Company in India. It has a long standing reputation in the fragrance industry developed in 96 years of experience. Its fragrance products and ingredients are used as
Slide 19: 18
18
S H Kelkar and Company — Q2 & H1 FY22 Earnings Presentation on 6ix